Articles
All (11)
SCI-E, SSCI, AHCI (11)
SCI-E, SSCI, AHCI, ESCI (11)
Scopus (11)
TRDizin (4)
2019
20191. A Novel ATP6V0A2 Mutation Causing Recessive Cutis Laxa with Unusual Manifestations of Bleeding Diathesis and Defective Wound Healing
Karacan İ., DIZ KÜÇÜKKAYA R., Karakuş F. N., Solakoğlu S., Tolun A., Hançer V. S., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.36, no.1, pp.29-36, 2019 (SCI-Expanded)
2018
20182. Glycoprotein Ib alpha Kozak polymorphism in patients presenting with early-onset acute coronary syndrome
Golcuk E., Yalin K., Akdeniz C. S., Teker E., Teker B., Hancer V. S., et al.
ARCHIVES OF MEDICAL SCIENCE
, vol.14, no.4, pp.788-793, 2018 (SCI-Expanded)
2013
20133. MPL W515L/K Mutations in Chronic Myeloproliferative Neoplasms.
Akpinar T. S., Hancer V. S., Nalcaci M., Diz-Kucukkaya R.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.30, no.1, pp.8-12, 2013 (SCI-Expanded, Scopus, TRDizin)
2012
20124. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis
Yonal I., Pinarbasi B., Hindilerden F., Hancer V. S., Nalcaci M., Kaymakoglu S., et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
, vol.34, no.3, pp.388-396, 2012 (SCI-Expanded)
2012
20125. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients
Hancer V. S., Diz-Kucukkaya R., Aktan M.
MEDICAL ONCOLOGY
, vol.29, no.2, pp.1068-1072, 2012 (SCI-Expanded)
2012
20126. Glycoprotein Ib-alpha Kozak polymorphism in ischemic stroke
Esen F. I., Hancer V. S., Kucukkaya R. D., Yesilot N., Coban O., Bahar S., et al.
NEUROLOGICAL RESEARCH
, vol.34, no.1, pp.68-71, 2012 (SCI-Expanded)
2011
20117. ADAMTS-13 gene expression in antiphospholipid syndrome
Hancer V. S., Kucukkaya R. D., Topal-Sarikaya A.
TURKISH JOURNAL OF HEMATOLOGY
, vol.28, no.3, pp.213-218, 2011 (SCI-Expanded)
2011
20118. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia
Hancer V. S., Kose M., Diz-Kucukkaya R., Yavuz A., Aktan M.
LEUKEMIA & LYMPHOMA
, vol.52, no.1, pp.79-84, 2011 (SCI-Expanded)
2010
20109. Cytotoxic T lymphocyte antigen-4 (CTLA-4) A49G polymorphism and autoimmune blood diseases
Akturk F., Hancer V. S., Kucukkaya R.
TURKISH JOURNAL OF HEMATOLOGY
, vol.27, no.2, pp.78-81, 2010 (SCI-Expanded)
2008
200810. Angiotensin-converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia: is DD genotype helpful in predicting syncope risk?
Ozben B., Altun I., Hancer V. S., Bilge A. K., Tanrikulu A. M., Diz-Kucukkaya R., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
, vol.9, no.4, pp.215-220, 2008 (SCI-Expanded)
2004
200411. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome
DIZ-KUCUKKAYA R., HANCER V. S., Inanc M., NALCACI M., PEKCELEN Y.
LUPUS
, vol.13, no.1, pp.32-35, 2004 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2015
20151. Two Pediatric Cases of Essential Thrombocytopenia Characterized By Extremely Rare Mutations (CALR and MPL W515K)
Tokgoz H., Caliskan U., Kucukkaya R., Demir A., Hancer V. S.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text)
2014
20142. Two Novel Mutations ( p.I454T and p.Y472X) and a Homozygous p.A109T Mutation Associated with Factor XI Deficiency in a Turkish Family
Gokgoz Z., Hancer V. S., Diz-Kucukkaya R.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text)
2012
20123. Can Activation Induced Cytidine Deaminase Lead to Genetic Instability in Bcr-Abl Negative Myeloproliferative Neoplasms?
Dermenci H., Daglar A., Akadam B. P., Hancer V. S., Gelmez Y., Aktan M., et al.
54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 8 - 11 December 2012, vol.120, (Summary Text)
2010
20104. Frequency and clinical outcomes of platelet membrane glycoprotein polymorphisms in antiphospholipid syndrome
Yonal I., Hindilerden F., Hancer V. S., Esen B. A., Nalcaci M., Kucukkaya R. D.
52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, United States Of America, 4 - 07 December 2010, vol.116, pp.1303-1304, (Summary Text)
2008
20085. Adamts-13 Gene Mutations and Transcription Analysis in Primary Antiphospholipid Syndrome
Hancer V. s., Diz-Kucukkaya R., topal-Sarikaya A.
50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2008, vol.112, pp.642, (Summary Text)
2006
20066. CTLA-4 A49G polymorphism and autoimmune blood diseases.
Akturk F., Hancer V. S., Guvenc S., Artim-esen B., Diz-Kucukkaya R.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)